Vice President Jagdeep Dhankhar's health history: AIIMS hospitalisation to Uttarakhand collapse—what really happened?
Point to ponder: Last week RSS chief Mohan Bhagwat advised 75 years as a 'retirement age' for public figures. Jagdeep Dhankar will be 75 only next May! So why now on day 1 of the monsoon session does he 'resign'? . Was health suddenly so bad (he was busily attending functions… pic.twitter.com/8ofROlGOIU
However, Jagdeep Dhanhkar's reasoning does seem to hold water when examining the outgoing VP's history of health crises. Specifically, his admittance into AIIMS for cardiac-related ailments, which occurred just a few weeks before he announced his resignation, as well as a fainting episode he had in Uttarakhand.
Jagdeep Dhankhar was hospitalized for heart issues
Jagdeep Dhankhar was admitted to AIIMS on March 9, at around 2 am after complaining of chest pains and discomfort. Dhankhar's was admitted to the medical institution's critical care unit, where he was closely monitored by a dedicated team of doctors.
Dhankhar's stint in AIIMS lasted for four days, with the hospitalization making the headlines. Several top Government officials, including Prime Minister Narendra Modi visited the VP during this time.
#BREAKING: Vice President of India Jagdeep Dhankar rushed to AIIMS after chest pain. He's currently under observation. pic.twitter.com/3xjuJi1Zzd
While Dhankhar claimed to have made a full recovery after being discharged from AIIMS, concerns about his health would reignite after he fainted in Uttarakhand, while attending Kumaon University's Golden Jubilee event in June of this year.
उपराष्ट्रपति धनखड़ के सीने में दर्द उठा: उत्तराखंड में पूर्व सांसद के गले लगकर रोए, तबीयत बिगड़ी तो जवानों ने संभालाhttps://t.co/OnPcWCEoTZ#JagdeepDhankhar #Uttarakhand pic.twitter.com/m7SRy99GLp
Jagdeep Dhankhar did not specify his health issue in his letter
Jagdeep Dhankhar's resignation letter did not get into specifics about what health concerns had prompted him to step down. Instead, Dhankar opted to thank the various people he worked with in the Indian Government, with his statement reading:
'I am deeply thankful for the invaluable experiences and insights I have gained as Vice President in our great democracy. It has been a privilege and satisfaction to witness and partake in India's remarkable economic progress and unprecedented exponential development during this significant period. Serving in this transformative era of our nation's history has been a true honor.'
With Jagdeep Dhankhar's sudden resignation, efforts will soon be underway to anoint India's next Vice President. The exact timeline of this process has not yet been made clear.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
26 minutes ago
- India Today
Why healthcare needs to be centre stage in Bihar elections
Hospitals with doctors missing. Operation theatres with equipment missing. Maternity wards with essential drugs missing. This is just the tip of Bihar's healthcare iceberg. As Bihar awaits Assembly elections, let's have a look at why healthcare needs to take centre stage in the man, machine, materialA 2024 CAG report on public health infrastructure and management of health services in Bihar noted that half the posts are empty in the state's health department. The state has one doctor available per 2,148 people, against a recommendation of one doctor per thousand Against specialists' requirement of 5,081, only 1,580 posts were filled in 2024 — 69 per cent of the posts remained vacant. Specifically, in terms of anaesthesia specialists, only 156 were in place, against the requirement of 1,129. While there was a requirement for 911 gynaecology doctors, only 375 were in place. This means 86 per cent of the posts were from lacking human resources, the state also has a scarcity of basic amenities. Drinking water, fans, separate toilets for males and females, chairs, etc., are missing in health centres — as is important equipment in emergency wards and operation theatres!In the sub-district hospitals of Barh, 71 per cent of essential equipment is missing in emergency wards; it's 84 per cent in operation theatres. The situation was found to be similar in Mahua, Makhdumpur, Bhagwanpur, Bakhtiyarpur, and 80 per cent of the essential drugs were missing for maternity services in Barh and Bhagwanpur. The seriousness of maternity conditions can be assessed by the fact that out of 24 cases of maternal deaths reported in 16 test-checked healthcare facilities from FY2016–22, a maternal death review was conducted in only one the physical verification of 25 ambulances showed that none of the ambulances had the required equipment. Also, six test-checked blood banks operated without a valid licence for up to 21 does Bihar's healthcare stand against SDG goals?According to India's Sustainable Development Goals for the United Nations, designed to be achieved by 2030, maternal mortality per lakh live births should be 70. While that number was 97 for the country in 2024, it was 118 for Bihar. Similarly, against a neonatal mortality rate goal of 12 or less, the Indian average was 24.9, and Bihar's was for improvement returnedThe odd thing is that, despite everything, Bihar has not stepped up to improve the healthcare conditions. 'The Government of Bihar had not prepared any comprehensive health policy/ plan, aligned with the National Health Policy, 2017, to address the gaps in infrastructure/equipment in every healthcare facility,' the CAG report said. As a result, the Bihar health department kept returning the money allotted for the financial years 2016 and 2022, a total of Rs 69,791 crore was provisioned for the Bihar health department, of which Rs 21,743 crore or 31 per cent was left report noted that the department kept releasing funds, which remained unutilised and were surrendered on the last day of that financial year.- EndsTune InMust Watch
Mint
34 minutes ago
- Mint
Cipla sees weight-loss drugs as the biggest opportunity in the Indian market
Drugmaker Cipla Ltd anticipates GLP-1 drugs, used for treating type-2 diabetes and obesity, to be a definite new therapy in the Indian market, and is exploring a wider foray, said chief executive Umang Vohra. 'The Indian market is particularly important to us, where we're looking at the whole GLP-1 category and not just Semaglutide alone,' Vohra told reporters in a media interaction on Friday after the company declared its June-quarter results. Semaglutide, a GLP-1 (glucagon-like peptide-1) drug sold under the brand name Wegovy in India by Novo Nordisk, goes off patent in March 2026. 'Our overall thinking is this is going to be pretty definitive in terms of a new therapy, in terms of a new section of the market and an opportunity that will be probably the biggest that we've seen in the last five years,' said Vohra. 'We're trying to evolve a strategy on what would make the most economic sense for us in this category.' The company also plans to launch Semaglutide in other markets where it goes off patent, although Vohra declined to name specific markets. Cipla will file to commercialize the product with partners as well as on its own, in what Vohra called a 'combination strategy'. 'We're going to be perhaps making two filings in some of the markets that are of importance across the world,' he said. The patent for Semaglutide is expiring in countries such as India, Canada, and Brazil in 2026. Cipla's first-quarter profit after tax (PAT) beat estimates, while its revenue was a miss. The company reported a PAT of ₹ 1,298 crore, up 10% year-on-year, against ₹ 1,198.5 crore, estimated by a Bloomberg poll of 22 brokerages. At ₹ 6,957 crore, its consolidated revenue increased 4% on-year but missed Bloomberg estimates of ₹ 7,057 crore. The company reported an Ebitda of ₹ 1,778 crore, up 4% on-year, with its Ebitda margin remaining steady on-year at 25.6%. Ebitda stands for earnings before interest, taxes, depreciation, and amortization. 'Underlying this performance has been the numbers from the One India business, which grew overall at 6% and within that, we've seen a higher growth from our [trade] generics and consumer healthcare business,' said Vohra, adding that branded prescription growth was lower on account of a muted season for acute therapies. The company reported $226 million in revenue from its North America business during the quarter, a drop of 9.6% from the previous year's revenue of $250 million. The North American business accounts for 28% of Cipla's revenues. 'This is in the range that we had guided at the beginning of this quarter…We've had two new launches, and our launch momentum hopes to continue as the rest of the year pans out,' Vohra said. While uncertainty over tariffs and regulatory shifts in the US continues, Vohra said Cipla's business is already significantly derisked. 'Fortunately or unfortunately, because of our facility issues that we've had in the last three years, due to citations at our sites, we had already started de-risking our business. And we built new facilities in the US,' he said. Vohra said while the firm expects some impact from US policy changes, it won't be a debilitating effect that will 'derail the way we've thought about our business'. Cipla also faces price erosion on blood cancer drug Revlimid and Lanreotide, used to treat neuroendocrine tumours, in the US this year. However, Vohra believes that the company has a product pipeline that will continue to drive growth over the next three to five years. Cipla's share price closed at ₹ 1,535.00 on Friday on National Stock Exchange, up 3.17%.
NDTV
an hour ago
- NDTV
Three Years On, MBBS In Hindi Slow To Take Off In Madhya Pradesh
Three years after Madhya Pradesh made headlines as the first Indian state to introduce MBBS (Bachelor of Medicine and Bachelor of Surgery) education in Hindi, the ambitious project is still struggling to find its pulse. In October 2022, the fanfare was loud - Hindi-translated medical textbooks were launched in Bhopal and the move was declared a "historic step." The promise? That the next generation of doctors would speak - and treat patients in - the language of the people. But when NDTV visited Gandhi Medical College in Bhopal, the state's premier government medical institute, the picture was more complex. "I studied in Hindi... but gave the exam in English," says Ankit Pandey, a second-year MBBS student. "No one stopped us from using Hindi, but everyone around us slowly shifted to English for better marks, for a better future." Ankit, like many others, comes from a Hindi-medium background. He entered the college thinking this experiment would bridge the language gap. But soon, reality hit: technical terms in Hindi were awkward, exam patterns still leaned towards English, and career prospects still demanded English proficiency. "This isn't about preference, it's about survival," adds Daksh, another student. "If I want to go for my post-graduation or work in a metro city, English is essential. If I only study in Hindi, I'll be a doctor trapped in a regional bubble." The government spent Rs 10 crore to print Hindi medical books, distribute them across libraries, and set up translation panels. "The books are available. But I haven't seen a single student take their Physiology exam in Hindi," says Dr Rakesh Malviya, President of the Medical Teachers' Association. The reason? It's not that students are rejecting the language, they are just unsure whether the system will reward it. There's no separate Hindi-medium form. No clear data. And, in an exam-driven profession, no one wants to risk uncertainty. Kavita Singh, Dean of Gandhi Medical College in Bhopal, said: "15-20% of students come from Hindi medium backgrounds. They struggle at first. But most eventually shift to English to keep up." In smaller towns like Jabalpur and Satna, however, the story is different. Here, students are actually writing exams in Hindi and doing well. Chetna Jharia, from Netaji Subhash Chandra Bose Medical College, says: "I gave the first-year exam in Hindi. When the books came in my language, I finally started understanding." Sheetal Kori, a student at Hitkarini Dental College, recalled, "When the question came in Hindi, I could answer freely. Earlier I used to lag behind, now I feel confident." But these success stories are a fairly small percentage of the total. The Vice Chancellor of the Madhya Pradesh Medical Science University, Dr Ashok Khandelwal, said, "We don't have exact numbers. Some colleges say 10-15% took theory exams in Hindi. Others say 50% used mixed language in practicals. But no comprehensive data exists." Government's Take Rajendra Shukla, Minister of Public Health & Medical Education, said, "Nearly 15 to 20 per cent of students are studying using a mix of Hindi and English, and they're doing quite well with it." Dr Lokendra Dave, nodal officer of the Hindi Cell, said the language is not being enforced on anybody. "This is a trust-building step. We're not enforcing Hindi. We're just creating space for it. A student should not be judged by the language they write in," he said.
